IDYA
Price
$15.12
Change
-$1.24 (-7.58%)
Updated
Apr 3, 03:18 PM (EDT)
Capitalization
1.43B
40 days until earnings call
MLTX
Price
$37.68
Change
-$0.37 (-0.97%)
Updated
Apr 3, 02:50 PM (EDT)
Capitalization
2.41B
35 days until earnings call
Ad is loading...

IDYA vs MLTX

Header iconIDYA vs MLTX Comparison
Open Charts IDYA vs MLTXBanner chart's image
IDEAYA Biosciences
Price$15.12
Change-$1.24 (-7.58%)
Volume$10.25K
Capitalization1.43B
MoonLake Immunotherapeutics
Price$37.68
Change-$0.37 (-0.97%)
Volume$237
Capitalization2.41B
IDYA vs MLTX Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. MLTX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and MLTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (IDYA: $16.35 vs. MLTX: $38.05)
Brand notoriety: IDYA and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 216% vs. MLTX: 171%
Market capitalization -- IDYA: $1.43B vs. MLTX: $2.41B
IDYA [@Biotechnology] is valued at $1.43B. MLTX’s [@Biotechnology] market capitalization is $2.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both IDYA and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • MLTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -6.25% price change this week, while MLTX (@Biotechnology) price change was -0.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.21%. For the same industry, the average monthly price growth was -10.32%, and the average quarterly price growth was -14.38%.

Reported Earning Dates

IDYA is expected to report earnings on May 13, 2025.

MLTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-8.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.41B) has a higher market cap than IDYA($1.43B). MLTX YTD gains are higher at: -29.732 vs. IDYA (-36.381). MLTX has higher annual earnings (EBITDA): -141.71M vs. IDYA (-323.14M). IDYA has more cash in the bank: 676M vs. MLTX (448M). MLTX has less debt than IDYA: MLTX (2.83M) vs IDYA (19.2M). IDYA has higher revenues than MLTX: IDYA (7M) vs MLTX (0).
IDYAMLTXIDYA / MLTX
Capitalization1.43B2.41B59%
EBITDA-323.14M-141.71M228%
Gain YTD-36.381-29.732122%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash676M448M151%
Total Debt19.2M2.83M678%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAMLTX
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
56%
Advances
ODDS (%)
Bullish Trend 22 days ago
77%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
53%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINIX42.240.15
+0.36%
MFS International Intrinsic Value I
HBIOX17.58N/A
N/A
Hartford International Opp HLS IB
LCGFX26.59N/A
N/A
William Blair Large Cap Growth I
SUSIX11.57N/A
N/A
State Street Instl US Equity Inv
HSXCX8.88N/A
N/A
Hartford Schroders Diversified Em Mkts C

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+4.68%
XENE - MLTX
47%
Loosely correlated
+2.68%
CLDX - MLTX
42%
Loosely correlated
+3.15%
DNLI - MLTX
41%
Loosely correlated
+11.80%
IDYA - MLTX
41%
Loosely correlated
+10.70%
KYMR - MLTX
39%
Loosely correlated
+4.46%
More